HHS.gov @HHSGov
NEWS: HHS and @DeptofDefense today announced an agreement with @LillyPad to purchase the first doses of the company’s #COVID19 investigational antibody therapeutic bamlanivimab, also known as LY-CoV555. https://t.co/ULwSc2I5LX — PolitiTweet.org